Prime Editing Unlocks a Universal Strategy for Restoring Lost Proteins
November 22, 2025
Brand Name :
Fiorinal with Codeine
Synonyms :
butalbital/aspirin/caffeine/codeine
Class :
Analgesics, opioid combos
Dosage forms and strengths Â
codeine/butalbital/aspirin/caffeineÂ
capsule-(Schedule III)Â
30mg /50mg/325mg/40mgÂ
Muscle Contraction Tension HeadacheÂ
1-2 tablets or capsules orally every 4 hours, with a maximum daily limit of 6 tablets or capsules
When discontinuing treatment, gradually reduce the dosage by 25% to 50% every 2-4 days while closely monitoring for any symptoms or signs of withdrawal
Dosage forms and strengthsÂ
codeine /butalbital/aspirin/caffeineÂ
capsule-(Schedule III)Â
30mg /50mg/325mg/40mgÂ
The use of codeine in children under the age of 12 and in pediatric patients undergoing tonsillectomy and adenoidectomy has been advised against by the FDAÂ
Muscle Contraction Tension HeadacheÂ
Age (≥16 years)- 1-2 tablets/capsules orally every 4 hours, ensuring not to exceed a maximum of 6 tablets/capsules within a 24 hours
Refer adult dosingÂ
Actions and SpectrumÂ
Action:Â
butalbital: BarbiturateÂ
aspirin: nonsteroidal anti-inflammatory drug (NSAID) Â
caffeine: caffeine is a stimulant that acts on the central nervous systemÂ
codeine: opioid analgesic Â
Spectrum:Â
The combination of butalbital, aspirin, caffeine, and codeine provides a broader spectrum of action compared to individual components alone. Â
It can effectively relieve tension headaches, migraines, and other pain-related muscle tension or inflammation.Â
Frequency defined Â
>10%Â
codeine Â
DrowsinessÂ
ConstipationÂ
1-10%Â
codeineÂ
BradycardiaÂ
DizzinessÂ
headacheÂ
HypotensionÂ
confusionÂ
tachycardia Â
lightheadednessÂ
false feeling of well beingÂ
paradoxical CNS stimulationÂ
urticariaÂ
malaiseÂ
restlessnessÂ
rash Â
Frequency not definedÂ
butalbitalÂ
DizzinessÂ
vomitingÂ
SedationÂ
DrowsinessÂ
Shortness of breathÂ
LightheadednessÂ
NauseaÂ
Intoxicated feelingÂ
Abdominal pain Â
aspirinÂ
Stomach painÂ
NauseaÂ
DyspepsiaÂ
Tinnitus (high or chronic dose)Â
VomitingÂ
RashÂ
HeartburnÂ
UrticariaÂ
Â
caffeineÂ
DiarrheaÂ
TremorÂ
TinnitusÂ
VomitingÂ
Nervousness, irritabilityÂ
Insomnia, restlessnessÂ
NauseaÂ
Black Box Warning:Â Â
Neonatal opioid withdrawal syndromeÂ
Life-threatening respiratory depressionÂ
Coadministration with benzodiazepinesÂ
Contraindication/caution:Â Â
CautionsÂ
Pregnancy warnings:    Â
Pregnancy category: N/AÂ
Lactation: Excreted into human milk is knownÂ
Pregnancy Categories:        Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.Â
Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
Pharmacology:Â Â
combining these four ingredients in butalbital/aspirin/caffeine/codeine provides a multimodal approach to pain relief.Â
Pharmacodynamics:Â Â
butalbital: Barbiturate,elicits generalized CNS depressant effectsÂ
codeine: analgesic ,Opioid agonistÂ
caffeine: The vasoconstrictive characteristics of cerebral blood vessels can offer potential benefits in managing headaches.Â
aspirin: The action on the hypothalamus leading to the production of antipyresis, as well as the anti-inflammatory effects, are believed to be due to the inhibition of prostaglandin synthetase. This inhibition leads to a reduction in the synthesis of thromboxane A2.Â
Pharmacokinetics:Â
AbsorptionÂ
butalbital: It is well-absorbed orally and reaches peak plasma concentrations within 1 to 2 hours.Â
aspirin: aspirin is also well-absorbed orally, with peak plasma concentrations reached within 1 to 2 hours.Â
caffeine: It is rapidly and almost completely absorbed after oral administration, with peak plasma concentrations reaching within 30 to 60 minutes.Â
codeine: It is well-absorbed orally, and peak plasma concentrations are typically reached within 1 to 2 hours.Â
DistributionÂ
butalbital: It has a moderate volume of distribution, indicating that it is distributed throughout the body.Â
aspirin: It has a relatively large volume of distribution, allowing it to distribute extensively into tissues.Â
caffeine: It has a large volume of distribution, indicating wide distribution in body tissues.Â
codeine: It has a moderate volume of distribution, indicating distribution throughout the body.Â
MetabolismÂ
butalbital: It undergoes hepatic metabolism primarily via the CYP2C19 enzyme.Â
aspirin: It is rapidly hydrolyzed to salicylic acid in the body.Â
caffeine: It undergoes hepatic metabolism primarily through cytochrome P450 1A2 (CYP1A2).Â
codeine: It undergoes hepatic metabolism via CYP2D6 to morphine, which is responsible for its analgesic effects.Â
Excretion and EliminationÂ
butalbital: It is primarily eliminated via hepatic metabolism and subsequent renal excretion of metabolites.Â
aspirin: It is excreted mainly through renal elimination as salicylic acid and its metabolites.Â
caffeine: It is primarily eliminated through hepatic metabolism and subsequent renal excretion of metabolites.Â
codeine: It undergoes renal excretion of unchanged drug and its metabolites.Â
Administration: Â
Oral administration of tablets/capsules in a prescribed dosageÂ
Patient information leafletÂ
Generic Name: butalbital/aspirin/caffeine/codeineÂ
Why do we use butalbital/aspirin/caffeine/codeine? Â
These combination drugs treat headaches and complex tension (muscle contraction) but can only be used if other non-opioid treatments are incapable.Â